September 2019 - ObsEva

ObsEva announces new composition of its Executive Committee

Posted on September 11, 2019 (September 11, 2019) by Shauna Dillon

Geneva, Switzerland and Boston, MA – September 11, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage…

Clinical Operations Manager

Posted on September 11, 2019 (September 11, 2019) by Shauna Dillon

View vacancy

The H.C. Wainwright 21st Annual Global Investment in NYC – September 10th 2019

Posted on September 10, 2019 (September 18, 2019) by Shauna Dillon

ObsEva to present at The H.C. Wainwright 21st Annual Global Investment

Posted on September 9, 2019 (September 9, 2019) by Shauna Dillon

Click here for webcast

ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of Action, Supporting Its Potential to Increase Live Birth Rate Following Embryo Transfer in IVF

Posted on September 3, 2019 (September 2, 2019) by Shauna Dillon

Results show decreased uterine contractions, increased endometrial blood flow and gene expression relevant for uterine receptivity to implantation 4Q:19 Read-out…